Craft

i2o Therapeutics

Total Funding

$4 M

i2o Therapeutics Summary

Company Summary

Overview
i2o Therapeutics is a company that develops an ionic liquid technology intended to develop the effective oral formulation. Its technology leverages the benefits of protecting the drug cargo and enhancing permeation across the epithelial lining, enabling people to intake peptides, proteins, and other injection-based drugs.
Type
Private
Status
Active
Founded
2019
Website
https://www.i2obio.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu